Aline Satie Takamiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aline Satie Takamiya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Galera Bernabé
Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil
2 shared publications - Glauco Issamu Miyahara
Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil
2 shared publications Ana Daniela Spínola‐Silva
Psychosomatic and Education Research Center Oral Oncology Center São Paulo State University (Unesp) School of Dentistry Araçatuba São Paulo Brazil
1 shared publication- Ana Lívia Santos‐Sousa
Psychosomatic and Education Research Center Oral Oncology Center São Paulo State University (Unesp) School of Dentistry Araçatuba São Paulo Brazil
1 shared publication - Bruna Amélia Moreira Sarafim-Silva
Psychosomatic Research Center, Oral Oncology Center, São Paulo State University (UNESP), School of Dentistry, Araçatuba, São Paulo, Brazil
1 shared publication Debora Barros Barbosa
Department of Dental Materials and Prosthodontics, Araçatuba Dental School, Univ Estadual Paulista - UNESP, Araçatuba, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 478
Clinicopathological and biobehavioral factors influence the onset and severity of oral mucositis in patients with head and neck cancer
Oral mucositis is a debilitating adverse effect of radiotherapy in head and neck cancer. It progresses from erythema to painful ulcerations, often causing infections, nutritional impairment, treatment interruption, and reduced survival. While treatment-related factors are well established, patient-related risk determinants remain insufficiently defined. Thus, this study investigated the association between the onset and peak severity of radiation-induced oral mucositis in patients with head and neck cancer and their clinicopathological, biobehavioral, and demographic characteristics. To carry out this study, patients diagnosed with head and neck cancer and undergoing mandatory radiotherapy treatment were recruited. Fifty patients undergoing radiotherapy were evaluated daily. The analysis focused on the onset and peak severity of oral mucositis. Chemotherapy was significantly associated ( P = 0.034) with earlier oral mucositis onset. Diabetes ( P = 0.017) and radiation dermatitis ( P = 0.017) were statistically associated with the severity of mucositis at the time of onset, while hypertension ( P = 0.030), diabetes ( P = 0.016), mild and moderate alcohol consumption ( P = 0.029), radiation dermatitis ( P = 0.001), odynophagia ( P = 0.022), burning mouth ( P = 0.003), difficulty with hygiene ( P = 0.020), and use of opioids ( P = 0.045) were associated with the most severe degrees at the peak of lesion. Severe smokers were associated with a greater occurrence of mucositis lesions in the lip region at two times. This study demonstrated that the interaction between clinicopathological and biobehavioral factors exhibits distinct patterns depending on the stage of oral mucositis progression. A comprehensive understanding of these complex relationships is crucial for developing targeted strategies to prevent severe mucositis and optimize treatment outcomes.
- 29 April 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 478
Open AccessClinicopathological and biobehavioral factors influence the onset and severity of oral mucositis in patients with head and neck cancer
Oral mucositis is a debilitating adverse effect of radiotherapy in head and neck cancer. It progresses from erythema to painful ulcerations, often causing infections, nutritional impairment, treatment interruption, and reduced survival. While treatment-related factors are well established, patient-related risk determinants remain insufficiently defined. Thus, this study investigated the association between the onset and peak severity of radiation-induced oral mucositis in patients with head and neck cancer and their clinicopathological, biobehavioral, and demographic characteristics. To carry out this study, patients diagnosed with head and neck cancer and undergoing mandatory radiotherapy treatment were recruited. Fifty patients undergoing radiotherapy were evaluated daily. The analysis focused on the onset and peak severity of oral mucositis. Chemotherapy was significantly associated ( P = 0.034) with earlier oral mucositis onset. Diabetes ( P = 0.017) and radiation dermatitis ( P = 0.017) were statistically associated with the severity of mucositis at the time of onset, while hypertension ( P = 0.030), diabetes ( P = 0.016), mild and moderate alcohol consumption ( P = 0.029), radiation dermatitis ( P = 0.001), odynophagia ( P = 0.022), burning mouth ( P = 0.003), difficulty with hygiene ( P = 0.020), and use of opioids ( P = 0.045) were associated with the most severe degrees at the peak of lesion. Severe smokers were associated with a greater occurrence of mucositis lesions in the lip region at two times. This study demonstrated that the interaction between clinicopathological and biobehavioral factors exhibits distinct patterns depending on the stage of oral mucositis progression. A comprehensive understanding of these complex relationships is crucial for developing targeted strategies to prevent severe mucositis and optimize treatment outcomes.
- Open Access
- 19 February 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (2) , e70404
Specific Depressive Symptoms and Primary Tumor Location as Potential Predictors of Smoking Maintenance After Head and Neck Cancer Treatment
Background: Despite the known benefits of smoking cessation for head and neck cancer (HNC) patients, a significant proportion continue to use tobacco after treatment. Although the causes of this phenomenon are multifactorial, the underlying psychological mechanisms are still poorly understood. Aim: Investigate the influence of sociodemographic, clinicopathological, and psychological factors on smoking cessation after treatment of HNC. Methods: This study included 71 smoking HNC patients who had completed cancer treatment for at least 12 months. Clinicopathological characteristics and anxiety and depression symptoms extracted the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were evaluated in the pre‐treatment period. Data on smoking history was assessed through a semi‐structured interview. Results: A proportion of patients with HNC patients (39.4%) continued to smoke immediately after completing cancer treatment, with this proportion rising to 43.7% after 12 months of treatment. Logistic regression analyses showed that the occurrence of the primary tumor in the oral cavity ( β = 6.891, P = 0.008) and the psychological symptom of sadness measured by the BDI ( β = 5.279, P = 0.023) were predictive of smoking maintenance 12 months after the end of cancer treatment. Feeling like a failure before cancer treatment was the only predictor variable for smoking maintenance immediately after and 12 months after the end of treatment ( β = 13.455, p < 0.001; β = 4.537, P = 0.043; respectively). Conclusion: This study presents exploratory insights that identifies pre‐treatment specific depressive symptoms and primary tumor location as promising predictive factors for continued tobacco use in patients treated for head and neck cancer.
- 19 February 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (2) , e70404
Open AccessSpecific Depressive Symptoms and Primary Tumor Location as Potential Predictors of Smoking Maintenance After Head and Neck Cancer Treatment
Background: Despite the known benefits of smoking cessation for head and neck cancer (HNC) patients, a significant proportion continue to use tobacco after treatment. Although the causes of this phenomenon are multifactorial, the underlying psychological mechanisms are still poorly understood. Aim: Investigate the influence of sociodemographic, clinicopathological, and psychological factors on smoking cessation after treatment of HNC. Methods: This study included 71 smoking HNC patients who had completed cancer treatment for at least 12 months. Clinicopathological characteristics and anxiety and depression symptoms extracted the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were evaluated in the pre‐treatment period. Data on smoking history was assessed through a semi‐structured interview. Results: A proportion of patients with HNC patients (39.4%) continued to smoke immediately after completing cancer treatment, with this proportion rising to 43.7% after 12 months of treatment. Logistic regression analyses showed that the occurrence of the primary tumor in the oral cavity ( β = 6.891, P = 0.008) and the psychological symptom of sadness measured by the BDI ( β = 5.279, P = 0.023) were predictive of smoking maintenance 12 months after the end of cancer treatment. Feeling like a failure before cancer treatment was the only predictor variable for smoking maintenance immediately after and 12 months after the end of treatment ( β = 13.455, p < 0.001; β = 4.537, P = 0.043; respectively). Conclusion: This study presents exploratory insights that identifies pre‐treatment specific depressive symptoms and primary tumor location as promising predictive factors for continued tobacco use in patients treated for head and neck cancer.
- 1 January 2021
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 118, 111341
Biocompatible silver nanoparticles incorporated in acrylic resin for dental application inhibit Candida albicans biofilm
- 1 January 2021
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 118, 111341
Biocompatible silver nanoparticles incorporated in acrylic resin for dental application inhibit Candida albicans biofilm